AstraZeneca To Deliver Vaccine Trial Data By Year’s End


(AP) – AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January.

The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., Britain and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.

Election Judge Worked Despite COVID-19 Diagnosis, Then Died

Previous article

Weakened Eta Drenches Honduras; Could Reach Gulf Of Mexico

Next article

You may also like

More in WORLD